- increased circulating serum albumin level / IMPC
- increased circulating total protein level / IMPC
- increased red blood cell distribution width / IMPC
- increased neutrophil cell number / IMPC
- decreased leukocyte cell number / IMPC
- decreased circulating chloride level / IMPC
- decreased locomotor activity / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating phosphate level / IMPC
- decreased lymphocyte cell number / IMPC
- decreased bone mineral density / IMPC
- decreased lean body mass / IMPC
- increased hematocrit / IMPC
- abnormal gait / IMPC
- increased circulating triglyceride level / IMPC
- female infertility / IMPC
- increased total body fat amount / IMPC
- increased circulating glucose level / IMPC
- male infertility / IMPC
- increased mean corpuscular hemoglobin / IMPC
- decreased bone mineral content / IMPC
- thrombocytopenia / IMPC
- impaired righting response / IMPC
- trunk curl / IMPC
- increased circulating calcium level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased eosinophil cell number / IMPC
- tremors / IMPC
- increased anxiety-related response / IMPC
- increased circulating potassium level / IMPC
- decreased spleen weight / IMPC
- abnormal locomotor behavior / IMPC
- enlarged liver / IMPC
- increased circulating HDL cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating fructosamine level / IMPC
- small seminal vesicle / IMPC
- limb grasping / IMPC
- increased hemoglobin content / IMPC
- increased circulating amylase level / IMPC
- increased monocyte cell number / IMPC
- increased circulating cholesterol level / IMPC
- decreased heart weight / IMPC
- increased mean corpuscular volume / IMPC
- increased mean platelet volume / IMPC
- decreased exploration in new environment / IMPC
- increased circulating iron level / IMPC
- abnormal bone structure / IMPC
C57BL/6N-Leprtm1a(EUCOMM)Wtsi/H
Status | Available to order |
EMMA ID | EM:07367 |
International strain name | C57BL/6N-Leprtm1a(EUCOMM)Wtsi/H |
Alternative name | EPD0548_5_G08 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Leprtm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Lepr |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0548_5_G08. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Obesity due to leptin receptor gene deficiency / Orphanet_179494
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal adipose tissue morphology / MGI
- increased brown adipose tissue amount / MGI
- abnormal circulating cholesterol level / MGI
- increased circulating LDL cholesterol level / MGI
- abnormal circulating glucose level / MGI
- hypoglycemia / MGI
- increased neutrophil cell number / MGI
- decreased leukocyte cell number / MGI
- abnormal vascular development / MGI
- abnormal myocardial fiber morphology / MGI
- altered response to myocardial infarction / MGI
- abnormal intestinal epithelium morphology / MGI
- short tail / MGI
- enlarged liver / MGI
- enlarged adrenal glands / MGI
- absent adrenal medulla / MGI
- enlarged spleen / MGI
- decreased motor neuron number / MGI
- abnormal female reproductive system morphology / MGI
- abnormal uterus morphology / MGI
- constricted vagina orifice / MGI
- increased body length / MGI
- decreased body length / MGI
- increased body weight / MGI
- obese / MGI
- decreased body weight / MGI
- weight loss / MGI
- increased body size / MGI
- increased metastatic potential / MGI
- reduced male mating frequency / MGI
- hypoactivity / MGI
- polydipsia / MGI
- abnormal eating behavior / MGI
- polyphagia / MGI
- abnormal spatial learning / MGI
- reduced long term potentiation / MGI
- abnormal cardiovascular system physiology / MGI
- abnormal lipid level / MGI
- hyperlipidemia / MGI
- increased circulating triglyceride level / MGI
- increased circulating free fatty acid level / MGI
- increased circulating HDL cholesterol level / MGI
- hyperglycemia / MGI
- abnormal circulating insulin level / MGI
- extended life span / MGI
- abnormal digestive system physiology / MGI
- increased circulating corticosterone level / MGI
- increased urine glucose level / MGI
- polyuria / MGI
- liver inflammation / MGI
- lung inflammation / MGI
- pancreas inflammation / MGI
- abnormal lactation / MGI
- absent long term depression / MGI
- reduced male fertility / MGI
- reduced female fertility / MGI
- infertility / MGI
- male infertility / MGI
- female infertility / MGI
- abnormal estrous cycle / MGI
- abnormal learning/memory/conditioning / MGI
- abnormal glucose homeostasis / MGI
- increased circulating insulin level / MGI
- premature death / MGI
- abnormal skeleton development / MGI
- abnormal blood circulation / MGI
- abnormal kidney morphology / MGI
- no abnormal phenotype detected / MGI
- abnormal CNS synaptic transmission / MGI
- abnormal functional residual capacity / MGI
- abnormal respiratory mechanics / MGI
- abnormal lung compliance / MGI
- abnormal CD4-positive, alpha beta T cell morphology / MGI
- increased IgE level / MGI
- abnormal acute inflammation / MGI
- heart left ventricle hypertrophy / MGI
- hepatic steatosis / MGI
- small uterus / MGI
- decreased circulating triglyceride level / MGI
- decreased corpora lutea number / MGI
- decreased mature ovarian follicle number / MGI
- abnormal pancreas physiology / MGI
- increased glucagon secretion / MGI
- increased circulating glucagon level / MGI
- small male preputial glands / MGI
- decreased circulating insulin level / MGI
- abnormal conditioned taste aversion behavior / MGI
- decreased systemic arterial blood pressure / MGI
- albuminuria / MGI
- increased insulin sensitivity / MGI
- delayed wound healing / MGI
- abnormal inhibitory postsynaptic currents / MGI
- increased urine protein level / MGI
- increased liver weight / MGI
- no phenotypic analysis / MGI
- increased vasoconstriction / MGI
- increased insulin secretion / MGI
- decreased insulin secretion / MGI
- short femur / MGI
- increased susceptibility to age related obesity / MGI
- abnormal locomotor activation / MGI
- abnormal gluconeogenesis / MGI
- decreased cardiac output / MGI
- abnormal pancreatic beta cell physiology / MGI
- abnormal insulin secretion / MGI
- abnormal nervous system morphology / MGI
- abnormal response/metabolism to endogenous compounds / MGI
- increased pancreatic beta cell number / MGI
- abnormal axon extension / MGI
- maternal effect / MGI
- increased left ventricle diastolic pressure / MGI
- abnormal myelin sheath morphology / MGI
- increased kidney weight / MGI
- abnormal circulating lipid level / MGI
- abnormal hormone level / MGI
- decreased lean body mass / MGI
- cardiac ischemia / MGI
- abnormal kidney papilla morphology / MGI
- abnormal kidney calyx morphology / MGI
- decreased muscle weight / MGI
- enlarged placenta / MGI
- increased susceptibility to autoimmune diabetes / MGI
- increased mean systemic arterial blood pressure / MGI
- abnormal vascular wound healing / MGI
- decreased adiponectin level / MGI
- abnormal endometrium morphology / MGI
- decreased uterus weight / MGI
- abnormal behavior / MGI
- abnormal CD8-positive, alpha beta T cell morphology / MGI
- increased susceptibility to parasitic infection / MGI
- decreased T cell proliferation / MGI
- decreased follicle stimulating hormone level / MGI
- decreased cardiac muscle contractility / MGI
- increased circulating VLDL cholesterol level / MGI
- increased circulating cholesterol level / MGI
- abnormal pancreatic islet morphology / MGI
- abnormal pancreatic beta cell morphology / MGI
- abnormal exocrine pancreas morphology / MGI
- abnormal intraocular pressure / MGI
- glomerulosclerosis / MGI
- abnormal oxygen consumption / MGI
- increased oxygen consumption / MGI
- decreased oxygen consumption / MGI
- improved glucose tolerance / MGI
- impaired glucose tolerance / MGI
- abnormal renal glomerulus morphology / MGI
- abnormal myocardium layer morphology / MGI
- insulin resistance / MGI
- decreased heart rate / MGI
- abnormal fat pad morphology / MGI
- homeostasis/metabolism phenotype / MGI
- growth/size/body region phenotype / MGI
- reproductive system phenotype / MGI
- abnormal nerve conduction / MGI
- abnormal axon morphology / MGI
- decreased oocyte number / MGI
- abnormal food intake / MGI
- abnormal energy expenditure / MGI
- increased susceptibility to weight gain / MGI
- increased percent body fat/body weight / MGI
- pancreatic islet hyperplasia / MGI
- decreased body temperature / MGI
- abnormal body temperature / MGI
- decreased urine albumin level / MGI
- abnormal eye electrophysiology / MGI
- increased creatinine clearance / MGI
- increased circulating glucose level / MGI
- decreased circulating glucose level / MGI
- decreased pulmonary ventilation / MGI
- periinsulitis / MGI
- abnormal hypothalamus physiology / MGI
- increased susceptibility to diet-induced obesity / MGI
- decreased circulating leptin level / MGI
- increased circulating leptin level / MGI
- decreased systemic arterial systolic blood pressure / MGI
- abnormal epididymal fat pad morphology / MGI
- increased glycosylated hemoglobin level / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- abnormal leukocyte morphology / MGI
- abnormal adrenal gland zona reticularis morphology / MGI
- abnormal osteoclast differentiation / MGI
- abnormal spatial reference memory / MGI
- increased circulating interleukin-6 level / MGI
- increased interleukin-6 secretion / MGI
- abnormal chemokine level / MGI
- abnormal chemokine secretion / MGI
- increased susceptibility to endotoxin shock / MGI
- abnormal interleukin level / MGI
- increased blood uric acid level / MGI
- anovulation / MGI
- increased enterocyte apoptosis / MGI
- decreased carbon dioxide production / MGI
- delayed estrous cycle / MGI
- absent estrous cycle / MGI
- abnormal diestrus / MGI
- abnormal metestrus / MGI
- absent estrus / MGI
- increased pancreatic beta cell mass / MGI
- increased pancreatic alpha cell number / MGI
- degranulated pancreatic beta cells / MGI
- decreased gonadal fat pad weight / MGI
- increased mesenteric fat pad weight / MGI
- decreased splenocyte number / MGI
- increased liver triglyceride level / MGI
- increased birth weight / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- decreased prostaglandin level / MGI
- increased total body fat amount / MGI
- increased omental fat pad weight / MGI
- decreased respiratory quotient / MGI
- increased liver glycogen level / MGI
- increased bone volume / MGI
- abnormal respiratory electron transport chain / MGI
- abnormal aerobic respiration / MGI
- abnormal circadian temperature homeostasis / MGI
- impaired adaptive thermogenesis / MGI
- expanded mesangial matrix / MGI
- increased food intake / MGI
- decreased cell death / MGI
- increased pancreatic islet cell apoptosis / MGI
- decreased response to antigen / MGI
- increased susceptibility to non-insulin-dependent diabetes / MGI
- adipose tissue inflammation / MGI
- abnormal locomotor circadian rhythm / MGI
- renal glomerular protein deposits / MGI
- renal glomerular immunoglobulin deposits / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).